Arid1a inactivation is correlated to worse prognosis and poor tumor differentiation and its conditional ablation in a KRAS-driven PDAC murine model accelerated significantly invasive tumors formation, a finding underlying its tumor suppressor potential. The gene discussed is KRAS; the disease is neoplasm.